|
VIIC, HMDI, BPAC, KERX, ARNA, BBDA
Our Stocks to Watch today include Vision Industries Corp. (OTCBB: VIIC), Delta Seaboard International Inc. (OTCBB: HMDI), Biopack Environmental Solutions Inc. (OTCBB: BPAC), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Arena Pharmaceuticals Inc. (NASDAQ: ARNA) and Bebida Beverage Co. (OTC: BBDA).
VISION INDUSTRIES CORPORATION (OTCBB: VIIC)
"Up 107.41% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/VIIC.php
Vision is a developer of zero emission electric/hydrogen hybrid powered vehicles and turnkey hydrogen fueling systems. Vision's proprietary electric/hydrogen hybrid drive system combines the superior acceleration of a battery powered electric vehicle with the extended range provided by a hydrogen fuel cell.
VIIC News:
May 11 - Vision Industries Receives a $27MM Purchase Order for 100 Zero-Emission Class 8 Trucks
Vision Industries Corp. (OTCBB: VIIC) announces that it has finalized the purchase order agreement for 100 Tyrano Class 8 Trucks with Total Transportation Services, Inc. (TTS-I) of Rancho Dominquez, California.
"It has been a long road from our letter of intent signed a year ago to the closing of definite agreements. However, it was a very productive process in which we could identify specific needs of the trucking industry and translate those needs into our technology," says Martin Schuermann, CEO of Vision Industries Corp. "I am looking forward to a long relationship between Vision and TTS-I."
The purchase agreement also allows TTS-I to purchase an additional three hundred Vision trucks, bringing the total value of a contract to approximately $108 million dollars.
"This Purchase Order demonstrates that the trucking industry has embraced the zero-emission platform," says Vic La Rosa, President of Total Transportation Services, Inc. "It will give regulatory agencies comfort in finally pushing the zero-emission technologies that are needed."
DELTA SEABOARD INTERNATIONAL INCORPORATED (OTCBB: HMDI)
"Up 123.33% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/HMDI.php
Delta Seaboard International, Inc. provides well site services for oil companies, and independent oil and natural gas companies in south and east Texas, and the Gulf Coast market. Its services include workover, plugging and abandonment, and well completion and recompletion services. The company owns one land-based rig in Louisiana and five land-based rigs in the Gulf Coast region of Texas. Delta Seaboard International, Inc. was founded in 1958 and is based in Kemah, Texas.
HMDI News:
No recent news for Delta Seaboard International, Inc. (OTCBB: HMDI).
BIOPACK ENVIRONMENTAL SOLUTIONS (OTCBB: BPAC)
"Up 220.00% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/BPAC.php
Biopack manufactures 100% biodegradable consumer packaging products from locally available sugar cane waste called Bagasse. Based in Hong Kong with manufacturing facilities in Jiangmen, China, Biopack has earned the “premium brand” label in the biodegradable packaging market in Europe. Distributed under the “Roots Biopack” trademark, Biopack’s unique line of compostable packaging is sold in 12 European countries, North America, Hong Kong, Taiwan and South Africa.
BPAC News:
No recent news on Biopack Environmental Solutions Inc. (OTCBB: BPAC).
KERYX BIOPHARMACEUTICALS INCORPORATED (NASDAQ: KERX)
"Up 15.24% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/KERX.php
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease and cancer. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is also developing KRX-0401 (perifosine), which is in Phase 3 clinical development for multiple myeloma. Keryx is headquartered in New York City.
KERX News:
May 10 - Keryx Biopharmaceuticals to Present at The 11th Annual JMP Securities Research Conference
Presentation Scheduled for Tuesday, May 15 at 12:00 noon PT
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 11th Annual JMP Securities Research Conference, which will be held at the Ritz Carlton Hotel in San Francisco. Mr. Bentsur's presentation is scheduled to take place on Tuesday, May 15, 2012 at 12:00 noon Pacific Time (3:00 p.m. Eastern).
A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.
ARENA PHARMACEUTICALS INCORPORATED (NASDAQ: ARNA)
"Up 73.77% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/ARNA.php
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company’s advanced stage drug candidate includes the lorcaserin for the treatment of weight management, including weight loss and maintenance of weight loss. Its product in clinical development comprises APD811, which is under Phase I clinical trial for the treatment of pulmonary arterial hypertension. The company’s preclinical development programs include APD334, an oral treatment for the treatment of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis; and APD371 for the treatment of pain. The company also researches and develops GPR119, a pharmaceutical target for discovering orally available small molecule agonists for the treatment of type 2 diabetes, as well as temanogrel, nelotanserin, and earlier-stage programs. In addition, the company provides manufacturing services. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
ARNA News:
May 11 - Reuters: Arena shares soar as experts recommend approval for obesity drug
According to Reuters, "Shares of Arena Pharmaceuticals Inc (NASDAQ: ARNA) nearly doubled in value after a panel of experts recommended approval of the company's obesity pill, a big step towards making it the first new diet drug on the U.S. market in more than a decade."
To read more, visit http://reut.rs/J5kVG9.
BEBIDA BEVERAGE COMPANY (OTC: BBDA)
"Up 25.00% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/BBDA.php
BeBevCo (Bebida Beverage Company) develops, manufactures and markets beverages including Koma Unwind "Chillaxation Drink™," Koma Unwind Sugar-free "Chillaxation Drink™," and Koma Unwind "Chillaxation Shot™" as well as Potencia Energy Drink, Potencia "BLAST" energy shot and Piranha Water.
BBDA News:
May 10 - Former Red Bull Driver Scott Speed to Pilot KOMA UNWIND Relaxation drink @ Darlington NASCAR Sprint Cup Event.
Bebida Beverage Company (OTC: BBDA) (BeBevCo), a developer, manufacturer and marketer of liquid relaxation products, announced the company has made a deal with Go Green Racing to be the primary sponsor on their NASCAR Sprint Cup series Ford. The fastest-growing relaxation drink in the world, KOMA UNWIND, will join Go Green Racing and their driver SCOTT SPEED for this week's installment at the "Too Tough to Tame" Darlington Speedway for the Bojangles Southern 500. This will be the team's second Sprint Cup attempt. Veteran Cup Champion crew Chief Paul Andrews will call the shots.
The Bojangles Southern 500 will be covered on the Fox Sports Network. The race starts at 7:00 PM Eastern Time.
Through the exposure of sponsorships, BeBevCo is on a mission to engage every NASCAR race fan on Facebook and Twitter @KOMAUNWINDnews from around the world.
"How cool is it when you can build your brand of relaxation drink by backing a driver with a history of building the number one energy drink in both Formula 1 and NASCAR Sprint Cup? Scott will do a great job for us," said BeBevCo CEO Brian Weber. "I bet Scott and his wife have a bigger need for a relaxation drink than energy drink now with a new baby!" said Brian Weber. "It doesn't matter if you're chilling by the pool, stressing before an exam or just had a stressful day, KOMA UNWIND is your liquid solution," added Brian.
|
